Adventa BhdXKLS:7191 29 Net Current Asset Value is RM0.05 as of Mar. 2026, which is 100% below its 10-year median of 3.03. GuruFocus rates XKLS:7191 with a GF Score™ of 29/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Adventa Bhd ranks better than 74.34% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Adventa Bhd's net current asset value per share for the quarter that ended in Mar. 2026 was RM0.05.
The historical rank and industry rank for Adventa Bhd's Net Current Asset Value or its related term are showing as below:
XKLS:7191'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.27 Med: 3.03 Max: 52.29
Current: 2.5
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Adventa Bhd was 52.29. The lowest was 1.27. And the median was 3.03.
XKLS:7191's Price-to-Net-Current-Asset-Value is ranked better than 74.34% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 4.99
vs XKLS:7191: 2.50
Adventa Bhd (XKLS:7191) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Adventa Bhd Net Current Asset Value Related Terms
Adventa Bhd Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Adventa Bhd's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7191 vs ISRG, BDX, MDLN: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Adventa Bhd's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adventa Bhd Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Adventa Bhd's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of RM0.05 mean?
Adventa Bhd (XKLS:7191) has a Net Current Asset Value of RM0.05 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Adventa Bhd and its competitors. This is 98% below median its historical median of 3.03. Over the past decade, Adventa Bhd's Net Current Asset Value has ranged from 1.27 to 52.29. According to the industry distribution chart, Adventa Bhd ranks #146 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 25.7%.
Is Adventa Bhd's Net Current Asset Value too high?
Adventa Bhd's current Net Current Asset Value of RM0.05 is 98% below median its 10-year median of 3.03. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 52.29. Based on the distribution chart, Adventa Bhd ranks #146 out of 569 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Adventa Bhd has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's Net Current Asset Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #146 out of 569 companies for Net Current Asset Value. This puts Adventa Bhd in the upper half of its industry. The industry median Net Current Asset Value is 4.99. Historically, Adventa Bhd's own Net Current Asset Value has ranged from 1.27 to 52.29 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Adventa Bhd and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adventa Bhd's current Net Current Asset Value is RM0.05, which is 98% below median its own 10-year median of 3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 47.9% below its estimated fair value. The current Net Current Asset Value is RM0.05, which is 98% below median its 10-year median of 3.03. Adventa Bhd's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current Net Current Asset Value is RM0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adventa Bhd (XKLS:7191) Overvalued in 2026?
Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued.
The current stock price of RM0.13 is trading 47.9% below its estimated GF Value™ of RM0.24.
GuruFocus considers Adventa Bhd to be Possible Value Trap.
Key valuation signals for XKLS:7191:
Net Current Asset Value: RM0.05 (98% below median its 10-year median of 3.03)
GF Value™: RM0.24 vs. price of RM0.13 (47.9% below fair value)
No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
29GF Score
Get the complete analysis for XKLS:7191
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7191 has been successfully added to your 
